When looking at the percentage of participants that dropped out of the trial due to adverse effects, 2-6% of patients in the cagrilintide group discontinued treatment early while 7% of the participants receiving liraglutide discontinued treatment early, These findings were in comparison to only 3% of test subjects from the placebo group that discontinued treatment due to adverse events [1]
aeruginosa resistance to imipenem
Retatrutide (LY-3437943) is a unipeptide that simultaneously activates GLP-1, GIP, and glucagon receptors
What Is Glutathione, and How Does It Work
Maintenance Phase: After the first month-and-a-half, transition to weekly or biweekly injections to sustain that energy, help you power through workouts, and keep your metabolism revved
The April 2025 FDA safety alert on compounded topical finasteride is the most important recent development